CurrentAmbetter NevadaPolicy CP.MP.184

Clinical Policy: Home Ventilators

Customize your policy alerts

Sign up for Ambetter Nevada Policy CP.MP.184 alerts

Get alerted when Policy CP.MP.184 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Medical necessity criteria for provision and continued use of noninvasive and invasive home ventilators for non‑Medicare health plans affiliated with Centene (Ambetter Nevada). Affects providers requesting coverage for home ventilators for enrolled members.

Policy Summary

PayerAmbetter Nevada

PolicyHome Ventilators (clinical policy)

Policy CodePolicy CP.MP.184

Change TypeNo material clinical changes

Effective Date

Next Review Date

Key ActionObtain prior authorization with documentation showing required diagnostic testing and that a respiratory assist device (RAD) is inappropriate.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Multiple

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentAmbetter NevadaPolicy CP.MP.184

Clinical Policy: Home Ventilators

Customize your policy alerts

Sign up for Ambetter Nevada Policy CP.MP.184 alerts

Get alerted when Policy CP.MP.184 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerAmbetter Nevada

PolicyHome Ventilators (clinical policy)

Policy CodePolicy CP.MP.184

Change TypeNo material clinical changes

Effective Date

Next Review Date

Key ActionObtain prior authorization with documentation showing required diagnostic testing and that a respiratory assist device (RAD) is inappropriate.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Multiple

Distinct initial indications

≥4 hrs/dayUsage threshold

E0465–E0468Referenced HCPCS

Overlap syndromesSecondary review

Clinical policyDocument type

Coverage Criteria for Home Ventilators

Initial therapy — Restrictive thoracic disorders / neuromuscular disease

Covered when ALL of the following are met for the initial request for the first three months:

Primary diagnosis: Documentation of a neuromuscular disease (e.g., amyotrophic lateral sclerosis) OR a severe thoracic cage abnormality (e.g., post-thoracoplasty for tuberculosis or severe kyphoscoliosis)

[[chunk 2]]

Physiologic criteria (one required): One of: (a) PaCO2 measured while awake and breathing room air or prescribed O2 ≥ 45 mm Hg; (b) Sleep oximetry demonstrates O2 saturation ≤ 88% for ≥5 minutes while on prescribed O2; (c) If neuromuscular disease present, maximal inspiratory pressure <60 cm H2O OR FVC <50% predicted.PaCO2 ≥45 mm Hg; SpO2 ≤88% ≥5 min; MIP<60 cm H2O or FVC<50%

[[chunk 2]]

RAD/CPAP exclusion: Documentation supports both: (a) member could not be appropriately treated with a respiratory assist device (RAD); AND (b) the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support).

[[chunk 2]]

COPD exclusion: Chronic obstructive pulmonary disease does not contribute significantly to the pulmonary limitation.

[[chunk 2]]

Initial therapy — COPD with chronic respiratory failure

Covered when ALL of the following are met for the initial request for the first three months:

Hypercapnia: PaCO2 ≥ 52 mm Hg measured by arterial blood gas while awake and breathing prescribed FiO2.PaCO2 ≥52 mm Hg

[[chunk 3]]

Sleep apnea not predominant: Sleep apnea is not the predominant cause of the hypercapnia. Formal sleep testing is not required if the medical record demonstrates sleep apnea is not predominant.

[[chunk 3]]

One of ventilation/oxygen requirements: One of: (a) Requires oxygen therapy at FiO2 ≥ 36% or ≥4 L nasal; (b) Requires ventilatory support >8 hours per 24-hour period; (c) Requires a home mechanical ventilator with alarms and an internal battery because member cannot effectively breathe independently for more than a few hours and interruption without alert would be life-threatening.FiO2 ≥36% or ≥4L; >8 hours/day

Initial therapy — Obesity hypoventilation syndrome (OHS)

Covered when ALL of the following are met for the initial request for the first three months:

BMI ≥ 30.BMI ≥30

[[chunk 3]]

Arterial blood gas: Initial arterial blood gas PaCO2 done while awake and breathing at baseline and prescribed FiO2 is ≥ 45 mm Hg.PaCO2 ≥45 mm Hg

[[chunk 3]]

Sleep study: Sleep-disordered hypoventilation documented by polysomnography and other conditions are not the primary cause of hypoventilation (e.g., lung parenchymal disease, airway disease, chest wall disorder other than obesity mass loading, medications, neurologic disorder, muscle weakness, or congenital/idiopathic central alveolar hypoventilation).

[[chunk 3]]

Continued therapy

Continued use of noninvasive home ventilators after the initial certification period is medically necessary when ALL of the following are met:

Minimum use: Device is used for at least an average of four hours per 24-hour period.≥4 hours/24 hr

[[chunk 4]]

Ongoing benefits and RAD/CPAP exclusion: Documentation supports both: (1) ongoing benefits from use of the device; AND (2) the noninvasive home ventilator is not being used to provide RAD or CPAP therapy (i.e., used to provide average volume assured pressure support).

[[chunk 4]]

Overlap syndromes — Special handling

Special handling

Overlap syndromes: Presence of more than one condition (such as COPD and sleep apnea) requires secondary review by a medical director.

[[chunk 4]]

Invasive ventilator — initial and ongoing use

Covered when used for long-term/chronic conditions affecting ability to maintain adequate respiratory status:

Examples of appropriate conditions: Long-term/chronic conditions such as neuromuscular disease, thoracic restrictive disease, or chronic respiratory failure following COPD may meet criteria for invasive ventilator use.

[[chunk 4]]

Second or back-up ventilator

A second or backup ventilator is medically necessary when one of the following is met:

Different purpose: Second ventilator to serve a different medical purpose from the first (e.g., different types needed for day versus night).

[[chunk 5]]

Back-up due to mobility or access: Back-up ventilator needed when member is confined to a wheelchair and requires a wheelchair-mounted ventilator during the day and another for bed use, or when residence is in remote areas with poor emergency access.

[[chunk 5]]

This policy requires that a noninvasive home ventilator not be used as a respiratory assist device (RAD) or as CPAP. For initial and continued coverage the documentation must show both that the member could not be appropriately treated with a RAD and that the ventilator "will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)."

When a ventilator is requested for COPD, restrictive thoracic disorders, neuromuscular disease, or obesity hypoventilation, the clinical criteria include specific physiologic thresholds (e.g., PaCO2 cutoffs, sleep oximetry or polysomnography findings, or respiratory muscle testing) and explicit statement that the device is intended to provide ventilatory support rather than RAD/CPAP. Requests that indicate the device will be used as RAD or CPAP do not meet these criteria.

Coverage determinations under this clinical policy are a guide to medical necessity and do not constitute a contract or guarantee of payment. All coverage decisions remain subject to the member's benefit documents, applicable state and federal requirements, and any Health Plan–level administrative policies and procedures.

Providers must verify member benefits and obtain any required authorizations prior to service; inconsistencies with state Medicaid provisions default to the state manual and the Health Plan may change or withdraw this clinical policy as allowed by contract and regulation.

Use of a noninvasive home ventilator is not medically necessary when the required physiologic thresholds and supporting documentation are not demonstrated. Examples include failure to show the required arterial PaCO2 values (e.g., PaCO2 ≥ 45 mm Hg for restrictive/neuromuscular indications or PaCO2 ≥ 52 mm Hg for COPD where specified), absence of documented sleep-disordered hypoventilation when required, or lack of documentation that the member could not be appropriately treated with a RAD.

Requests may be denied if documentation instead indicates the device will be used as RAD/CPAP, or if COPD significantly contributes to the pulmonary limitation when the COPD-specific criteria are not met.

Coding and Usage Thresholds

Covered HCPCS Codes (referenced)HCPCS

E0465	Home ventilator, any type, used with invasive interface (e.g., tracheostomy tube)
E0466	Home ventilator, any type, used with noninvasive interface (e.g., mask, chest shell)
E0467	Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions
E0468	Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions

inv-12: Usage threshold for continued coverage

Usage threshold for continued coverageDevice is used for at least an average of four hours per 24-hour period.

Documentation required for continuationDocumentation must show ongoing benefit from device use and that it is not being used as RAD/CPAP.

Measurement periodAverage calculated over a 24-hour period per device usage records or clinical documentation.

inv-13: PaCO2 threshold (restrictive/neuromuscular)

PaCO2 threshold (restrictive/neuromuscular)An arterial blood gas PaCO2 measured while awake and breathing room air or prescribed O2 ≥ 45 mm Hg.

Context for measurementMeasurement must be taken while member/enrollee was stable (not in acute respiratory failure).

Provider Actions, Documentation, and Prior Authorization

Prior Authorization

Prior Authorization Required

Prior authorization is required for all requests for noninvasive home ventilators. Providers must obtain prior authorization before initial provision and before continuation beyond the initial certification period. Prior authorization requests should include all required clinical documentation (see documentation callouts) to allow timely coverage determination. Verify member eligibility and benefit terms; coverage is subject to the member's contract, plan terms, and any state or federal program requirements.

Prior authorization required for initial and continued use
Verify member eligibility and benefit terms prior to submission
Coverage subject to contract terms, exclusions, and state/federal requirements

Documentation Required

Documentation and Professional Responsibility

Providers must exercise professional medical judgment when diagnosing and treating members. This policy is a guide to medical necessity used to assist coverage decisions but is not a substitute for clinical judgment. Providers are responsible for the accuracy and completeness of the medical record, for obtaining informed consent, and for documenting the rationale for ventilator therapy. Requests will be reviewed in conjunction with this clinical policy, member coverage documents, and applicable Health Plan administrative policies and procedures.

Background

Respiratory failure refers to the inability to adequately oxygenate or ventilate. It may be acute or chronic and arise from conditions such as neuromuscular disease, thoracic cage restriction, COPD, or obesity hypoventilation.

Supportive respiratory technologies include noninvasive ventilation (NIV), which delivers positive pressure through interfaces such as nasal or full-face masks, and invasive ventilation, which delivers positive pressure via an invasive airway (for example, a tracheostomy or endotracheal tube). Home ventilator therapy aims to support gas exchange, reduce symptoms, improve quality of life, and decrease hospital readmissions and mortality when used according to the clinical criteria in this policy.

Definitions

inv-25: Noninvasive ventilation (NIV)

Definition — Noninvasive ventilation (NIV)Administration of positive pressure to the lungs using interfaces such as nasal masks, orofacial masks, full face masks, mouthpieces, nasal pillows, or helmets.

Common interfacesIncludes nasal masks, oronasal masks, mouthpieces, nasal pillows, and helmets.

Primary goalsProvides ventilatory support in the home setting for acute and chronic respiratory failure.

inv-26: Invasive ventilation

Definition — Invasive ventilationAdministration of positive pressure to the lungs through an invasive interface, such as a tracheostomy tube or endotracheal tube.

Use caseUsed when patients no longer have capacity to breathe spontaneously or ventilatory needs exceed their ability.

Policy Summary

PayerAmbetter Nevada

PolicyHome Ventilators (clinical policy)

Policy CodePolicy CP.MP.184

Change TypeNo material clinical changes

Effective Date

Next Review Date

Key ActionObtain prior authorization with documentation showing required diagnostic testing and that a respiratory assist device (RAD) is inappropriate.

SourceLink

On This Page

RAD/CPAP exclusion: Documentation supports both: (a) member could not be appropriately treated with a RAD; AND (b) the noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support).

[[chunk 3]]

Alternative physiologic criteriaSleep oximetry O2 saturation ≤88% for ≥5 minutes or neuromuscular-specific MIP/FVC thresholds may substitute per criteria.

inv-14: PaCO2 threshold (COPD)

PaCO2 threshold (COPD)Member/enrollee exhibits hypercapnia demonstrated by PaCO2 ≥ 52 mm Hg measured by arterial blood gas while awake and breathing prescribed FiO2.

Sleep apnea considerationSleep apnea must not be the predominant cause of hypercapnia; formal sleep testing not required if medical record supports this.

Associated ventilation criteriaMember must also meet one of the ventilation/oxygen requirements (e.g., FiO2 ≥36% or >8 hours/day).

inv-15: BMI threshold (OHS)

BMI threshold for OHSBMI ≥ 30.

PaCO2 requirementAn initial arterial blood gas PaCO2, done while awake and breathing at baseline and the prescribed FiO2, is ≥ 45 mm Hg.

Sleep study requirementSleep-disordered hypoventilation must be documented by polysomnography and other causes excluded.

Providers are independent contractors and are responsible for treatment decisions
Policy guides medical necessity determinations but does not dictate care
Decisions incorporate the clinical policy plus member contract and administrative policies

Documentation Required

Required Clinical Documentation

Provide complete clinical documentation with each prior authorization request. At minimum include: diagnostic testing results (arterial blood gas with PaCO2 values, sleep oximetry or polysomnography when indicated), documentation of underlying diagnosis (e.g., neuromuscular disease, severe thoracic cage abnormality, COPD, or obesity hypoventilation syndrome), objective measures of respiratory muscle strength or pulmonary function when applicable (maximal inspiratory pressure, forced vital capacity), and statements confirming that the member could not be appropriately treated with a respiratory assist device (RAD) and that the ventilator will not be used solely for RAD or CPAP therapy. Failure to submit required documentation may result in denial.

Include arterial blood gas results with PaCO2 values and date of test
Include sleep oximetry or polysomnography if indicated to document sleep-disordered hypoventilation
Document underlying diagnosis (neuromuscular disease, thoracic cage abnormality, COPD, OHS) and relevant objective measures (MIP, FVC)
Confirm RAD trial documentation and that ventilator will provide AVAPS/volume-assured support, not RAD/CPAP
Incomplete documentation may trigger denial of the request

Denial Risk

Denial Triggers and Coverage Constraints

Requests that do not meet the policy's clinical criteria or that lack necessary supporting documentation may be denied. Denials and coverage decisions are subject to all terms, conditions, exclusions and limitations of the member's coverage documents and to applicable state and federal requirements. Secondary review by a medical director is required for overlap syndromes (e.g., COPD with sleep apnea) and may be requested when documentation is unclear or conflicting.

Denials possible if PaCO2 or other diagnostic thresholds are not met or not documented
Coverage constrained by member contract, exclusions, and state/federal regulations
Medical director review required for overlap syndromes or unclear cases

SettingMay be used for long-term/chronic conditions requiring ongoing ventilatory support at home.

inv-27: Health Plan

Definition — Health PlanHealth Plan means a health plan that has adopted this clinical policy and that is operated or administered, in whole or in part, by Centene Management Company, LLC, or affiliates.

Policy roleThis clinical policy guides medical necessity determinations but does not constitute a contract or guarantee of payment.

ApplicabilityCoverage decisions are subject to terms, conditions, exclusions and limitations of the member's coverage documents and applicable law.